Orleans Capital Management Corpla Lowers stake in Becton Dickinson and Co (BDX)

Becton Dickinson and Co (BDX) : Orleans Capital Management Corpla reduced its stake in Becton Dickinson and Co by 2.12% during the most recent quarter end. The investment management company now holds a total of 21,320 shares of Becton Dickinson and Co which is valued at $3,709,254 after selling 462 shares in Becton Dickinson and Co , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Becton Dickinson and Co makes up approximately 2.55% of Orleans Capital Management Corpla’s portfolio.

Other Hedge Funds, Including , Babson Capital Management boosted its stake in BDX in the latest quarter, The investment management firm added 13,480 additional shares and now holds a total of 18,761 shares of Becton Dickinson and Co which is valued at $3,264,039. Becton Dickinson and Co makes up approx 0.16% of Babson Capital Management’s portfolio.Wespac Advisors Socal boosted its stake in BDX in the latest quarter, The investment management firm added 50 additional shares and now holds a total of 66 shares of Becton Dickinson and Co which is valued at $11,483. Becton Dickinson and Co makes up approx 0.01% of Wespac Advisors Socal’s portfolio.Rothschild Asset Management Inc boosted its stake in BDX in the latest quarter, The investment management firm added 13,219 additional shares and now holds a total of 83,926 shares of Becton Dickinson and Co which is valued at $14,752,512. Becton Dickinson and Co makes up approx 0.26% of Rothschild Asset Management Inc’s portfolio.Cardinal Capital Management reduced its stake in BDX by selling 351 shares or 1.21% in the most recent quarter. The Hedge Fund company now holds 28,701 shares of BDX which is valued at $5,051,376. Becton Dickinson and Co makes up approx 2.00% of Cardinal Capital Management’s portfolio.Trust Co Of Vermont boosted its stake in BDX in the latest quarter, The investment management firm added 631 additional shares and now holds a total of 37,729 shares of Becton Dickinson and Co which is valued at $6,632,004. Becton Dickinson and Co makes up approx 0.86% of Trust Co Of Vermont’s portfolio.

Becton Dickinson and Co closed down -0.19 points or -0.11% at $177.02 with 6,09,017 shares getting traded on Thursday. Post opening the session at $177.71, the shares hit an intraday low of $175.71 and an intraday high of $177.78 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Becton Dickinson and Co reported $2.35 EPS for the quarter, beating the analyst consensus estimate by $ 0.15 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $2.20. The company had revenue of $3198.00 million for the quarter, compared to analysts expectations of $3202.11 million. The company’s revenue was up 2.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.05 EPS.

Investors should note that on Jul 26, 2016, Becton Dickinson and Co announced a cash dividend of $0.6600. The company’s management has announced Sep 7, 2016 as the ex-dividend date and fixed the record date on Sep 9, 2016. The payable date has been fixed on Sep 30, 2016.

Becton Dickinson and Company is a global medical technology company engaged in the development manufacture and sale of a range of medical supplies devices laboratory equipment and diagnostic products used by healthcare institutions life science researchers clinical laboratories pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Company’s Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Company’s BD Medical segment focuses on providing solutions to reduce the spread of infection enhance diabetes treatment and advance drug delivery. The Company’s BD Diagnostics provides products for the safe collection and transport of diagnostics specimens as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers clinical researchers laboratory professionals and clinicians.

Leave a Reply

Becton Dickinson and Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Becton Dickinson and Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.